NCTC
AZN icon

New Covenant Trust Company’s AstraZeneca AZN Stock Holding History

New Covenant Trust Company’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-90
Closed -$12.1K – 109
2024
Q1 		$12.1K Buy
+90
New +$11.9K 0.01% 319

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

New Covenant Trust Company's AZN Position: Q2 2024 in Review

New Covenant Trust Company sold out of AstraZeneca (AZN) in Q2 2024, closing a stake of 90 shares — an estimated $12.1K sold.

New Covenant Trust Company first reported a position in AZN in Q1 2024 and held it in 1 quarter. The position peaked at $12.1K in Q1 2024. 1,211 funds tracked by Wall St. Rank hold AZN as of Q2 2024.

  • New Covenant Trust Company reported no remaining AstraZeneca position as of Q2 2024 after selling out during the quarter.
  • New Covenant Trust Company sold 90 AstraZeneca shares in Q2 2024, an estimated $12.1K.
  • New Covenant Trust Company first reported a position in AstraZeneca in Q1 2024 and held it in 1 quarter.
  • New Covenant Trust Company's AstraZeneca position peaked at $12.1K in Q1 2024.
  • 1,211 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2024.

Based on New Covenant Trust Company's 13F filing for Q2 2024, filed 30 Jul 2024.